✦ LIBER ✦

Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: Results from a randomized double-blind study

✍ Scribed by Joshi, S.S.; Bishop, M.R.; Lynch, J.C.; Tarantolo, S.R.; Abhyankar, S.; Bierman, P.J.; Vose, J.M.; Geller, R.B.; McGuirk, J.; Foran, J.; Bociek, R.G.; Hadi, A.; Day, S.D.; Armitage, J.O.; Kessinger, A.; Pavletic, Z.S.

Book ID: 122288605
Publisher: Informa plc
Year: 2003
Tongue: English
Weight: 134 KB
Volume: 5
Category: Article
ISSN: 1465-3249
DOI: 10.1080/14653240310003648

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Double Blind, Placebo-Contro

Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study

✍ Yanik, Gregory; Ho, Vincent T.; Horowitz, Mary; Weisdorf, Daniel J.; Logan, Bren 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A double-blind randomized placebo-contro

A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study

✍ Aquino, V M; Harvey, A R; Garvin, J H; Godder, K T; Nieder, M L; Adams, R H; Jac 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Effects of a phosphodiesterase type 5 in

Effects of a phosphodiesterase type 5 inhibitor (SILDENAFIL) evaluated by 24-hour blood pressure monitoring and exercise capacity in heart transplanted patients. A double-blind, placebo-controlled, cross-over, randomized study. Preliminary results

✍ G.V. Guimaraes; V.M. d’Avila; P.V. Pires; F.D. Cruz; N.A. Stolf; P.R. Chizzola; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB